Sign In
Buy NVAX
$10.20
-0.0100 (-0.0979%)
At Close: Jun 03, 2026
Novavax Investors Can Finally Breathe a Sigh of Relief
12:00pm, Wednesday, 16'th Feb 2022 The Motley Fool
Novavax's milestone means investors can now exhale.
Novavax Investors Can Finally Breathe a Sigh of Relief
12:00pm, Wednesday, 16'th Feb 2022 The Motley Fool
Novavax''s milestone means investors can now exhale.
Will Novavax Stock Ever Hit $300 Again?
11:25am, Wednesday, 16'th Feb 2022 The Motley Fool
On paper it's possible, but don't hold your breath.
Will Novavax Stock Ever Hit $300 Again?
11:25am, Wednesday, 16'th Feb 2022 The Motley Fool
On paper it''s possible, but don''t hold your breath.
3 Biotech Stocks to Buy in February
10:56am, Wednesday, 16'th Feb 2022 The Motley Fool
Their long-term prospects appear to be bright.
Novavax Stock Has Growth Ahead Whether It Missed the Boat or Not
09:10pm, Tuesday, 15'th Feb 2022 InvestorPlace
InvestorPlace - Stock Market News, Stock Advice & Trading Tips NVAX stock has been derided as a ran in the vaccine race, avoid that narrative and remain optimistic because the best is ahead for Novavax. The post Novavax Stock Has Growth Ahead Whether It Missed the Boat or Not appeared first on InvestorPlace . More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Man Who Called Black Monday: “Prepare Now.” Get in Now on Tiny $3 ‘Forever Battery’ Stock Interested in Crypto? Read This First…
Why I’m Done With Novavax Stock
08:14pm, Tuesday, 15'th Feb 2022 InvestorPlace
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Management is terrible at delivering on its promises and even good news has failed to translate into higher prices for NVAX stock. The post Why I’m Done With Novavax Stock appeared first on InvestorPlace . More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Man Who Called Black Monday: “Prepare Now.” #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First…
Shipment Delays Threaten the Best Advantage Novavax Has
06:19pm, Tuesday, 15'th Feb 2022 InvestorPlace
InvestorPlace - Stock Market News, Stock Advice & Trading Tips The latest setback for NVAX stock is lower than expected delivery numbers for its Covid-19 vaccine. The longer it takes to get its vaccine into arms, the more it risks losing a critical advantage. The post Shipment Delays Threaten the Best Advantage Novavax Has appeared first on InvestorPlace . More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Man Who Called Black Monday: “Prepare Now.” Get in Now on Tiny $3 ‘Forever Battery’ Stock Interested in Crypto? Read This First…
Why Novavax, Dynavax, and Ocugen Are All Rising Today
05:40pm, Tuesday, 15'th Feb 2022 The Motley Fool
A broad stock market rebound and an encouraging survey appear to be boosting these vaccine stocks.
Why Novavax, Dynavax, and Ocugen Are All Rising Today
05:40pm, Tuesday, 15'th Feb 2022 The Motley Fool
A broad stock market rebound and an encouraging survey appear to be boosting these vaccine stocks.
Can Novavax Stock Double in 2022?
10:52am, Tuesday, 15'th Feb 2022 The Motley Fool
Spoiler alert: The answer is "yes."
Can Novavax Stock Double in 2022?
10:52am, Tuesday, 15'th Feb 2022 The Motley Fool
Spoiler alert: The answer is "yes."
Where to get the Novavax jab in NSW
06:18am, Tuesday, 15'th Feb 2022 The Daily Telegraph
The long-awaited Novavax is set to be rolled out in pharmacies and GP clinics across NSW and experts say it could be the answer for patients looking for a “more traditional vaccine”.
The New Kid on the Covid-Vaccine Block
11:21pm, Monday, 14'th Feb 2022 The Wall Street Journal
Novavax, up for FDA authorization, will be a good booster option.
Novavax COVID vaccine gets interim authorization in Singapore By Reuters
09:20pm, Monday, 14'th Feb 2022 Investing.com
Novavax COVID vaccine gets interim authorization in Singapore
